Veraxa Biotech to merge with SPAC Voyager in $1.64 billion deal
23/04/2025 06:19
April 23 (Reuters) - Switzerland's Xlife Sciences AG XLS.S said on Wednesday its portfolio company, VERAXA Biotech AG, will merge with Voyager Acquisition VACH.O in a deal that will value the combined company at $1.64 billion. (Reporting by Bipasha Dey in Bengaluru; Editing by Janane Venkatraman) ((Bipasha.Dey@thomsonreuters.com;))